scispace - formally typeset
H

H. B. Woodruff

Researcher at Merck & Co.

Publications -  11
Citations -  1465

H. B. Woodruff is an academic researcher from Merck & Co.. The author has contributed to research in topics: Cefoxitin & Streptomyces. The author has an hindex of 9, co-authored 11 publications receiving 1403 citations.

Papers
More filters
Journal ArticleDOI

Phosphonomycin, a New Antibiotic Produced by Strains of Streptomyces

TL;DR: Phosphonomycin is a newly discovered antibiotic produced by streptomycetes that is effective, when administered by the oral route, to mice infected with Gram-positive or Gram-negative microorganisms.
Journal ArticleDOI

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

TL;DR: A new beta-lactam antibiotic, named thienamycin, was discovered in culture broths of Streptomyces MA4297, and subsequently determined to be a hitherto unrecognized species, is designated StrePTomyces cattleya (NRRL 8057).
Journal ArticleDOI

Cephamycins, a New Family of β-Lactam Antibiotics I. Production by Actinomycetes, Including Streptomyces lactamdurans sp. n

TL;DR: A number of actinomycetes isolated from soil were found to produce one or more members of a new family of antibiotics, the cephamycins, which are structurally related to cephalosporin C.
Journal ArticleDOI

Fosfomycin: Laboratory studies.

TL;DR: Fosfomycin, a nontoxic broad-spectrum antibiotic, different in structure from all previously described antibiotics, acts selectively by inhibiting cell wall formation and has favorable pharmacologic characteristics.
Journal ArticleDOI

Cefoxitin and Cephamycins: Microbiological Studies

TL;DR: The therapeutic effectiveness of cefoxitin in experimental infections in mice confirms the excellent characteristics of this semisynthetic cephamycin and indicates that it should be a very valuable agent for treatment of bacterial infections.